chemotherapy induced peripheral neuropathy treatment market

Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Analysis 2016-2020 and Forecast 2021-2026

  • Published Date: 2021-02-28
  • Report ID: 64400
  • Pages: 156
  • Format: prudent report format

Snapshot

The global Chemotherapy Induced Peripheral Neuropathy Treatment market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Chemotherapy Induced Peripheral Neuropathy Treatment by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
APX-3330
BR-297
Cannabidiol
Dimiracetam
Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Achelios Therapeutics Inc
Advinus Therapeutics Ltd
Apollo Endosurgery Inc
Aptinyx Inc
Asahi Kasei Pharma Corp
Can-Fite BioPharma Ltd
Celgene Corp
DermaXon LLC
Eisai
Immune Pharmaceuticals Inc
INSYS Therapeutics Inc
Kineta Inc
KPI Therapeutics Inc
Krenitsky Pharmaceuticals Inc
MAKScientific LLC
Metys Pharmaceuticals AG
Midatech Pharma US Inc
Mundipharma International Ltd
Nemus Bioscience Inc
Neurocentrx Pharma Ltd
Panacea Pharmaceuticals Inc
PeriphaGen Inc
PharmatrophiX Inc
PledPharma AB
Sova Pharmaceuticals Inc
Virobay Inc
WEX Pharmaceuticals Inc

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Clinic
Hospital
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)


Table of Contents
1 Industry Overview
1.1 Chemotherapy Induced Peripheral Neuropathy Treatment Industry
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Chemotherapy Induced Peripheral Neuropathy Treatment
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Chemotherapy Induced Peripheral Neuropathy Treatment
1.2.2 Downstream
Table Application Segment of Chemotherapy Induced Peripheral Neuropathy Treatment
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Chemotherapy Induced Peripheral Neuropathy Treatment Market by Type
3.1 By Type
3.1.1 APX-3330
Table Major Company List of APX-3330
3.1.2 BR-297
Table Major Company List of BR-297
3.1.3 Cannabidiol
Table Major Company List of Cannabidiol
3.1.4 Dimiracetam
Table Major Company List of Dimiracetam
3.1.5 Others
Table Major Company List of Others
3.2 Market Size
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market 2016-2020, by Type, in USD Million
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Growth 2016-2020, by Type, in USD Million
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market 2016-2020, by Type, in Volume
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast 2021-2026, by Type, in USD Million
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Achelios Therapeutics Inc (Company Profile, Sales Data etc.)
4.1.1 Achelios Therapeutics Inc Profile
Table Achelios Therapeutics Inc Overview List
4.1.2 Achelios Therapeutics Inc Products & Services
4.1.3 Achelios Therapeutics Inc Business Operation Conditions
Table Business Operation of Achelios Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Advinus Therapeutics Ltd (Company Profile, Sales Data etc.)
4.2.1 Advinus Therapeutics Ltd Profile
Table Advinus Therapeutics Ltd Overview List
4.2.2 Advinus Therapeutics Ltd Products & Services
4.2.3 Advinus Therapeutics Ltd Business Operation Conditions
Table Business Operation of Advinus Therapeutics Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Apollo Endosurgery Inc (Company Profile, Sales Data etc.)
4.3.1 Apollo Endosurgery Inc Profile
Table Apollo Endosurgery Inc Overview List
4.3.2 Apollo Endosurgery Inc Products & Services
4.3.3 Apollo Endosurgery Inc Business Operation Conditions
Table Business Operation of Apollo Endosurgery Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Aptinyx Inc (Company Profile, Sales Data etc.)
4.4.1 Aptinyx Inc Profile
Table Aptinyx Inc Overview List
4.4.2 Aptinyx Inc Products & Services
4.4.3 Aptinyx Inc Business Operation Conditions
Table Business Operation of Aptinyx Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Asahi Kasei Pharma Corp (Company Profile, Sales Data etc.)
4.5.1 Asahi Kasei Pharma Corp Profile
Table Asahi Kasei Pharma Corp Overview List
4.5.2 Asahi Kasei Pharma Corp Products & Services
4.5.3 Asahi Kasei Pharma Corp Business Operation Conditions
Table Business Operation of Asahi Kasei Pharma Corp (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Can-Fite BioPharma Ltd (Company Profile, Sales Data etc.)
4.6.1 Can-Fite BioPharma Ltd Profile
Table Can-Fite BioPharma Ltd Overview List
4.6.2 Can-Fite BioPharma Ltd Products & Services
4.6.3 Can-Fite BioPharma Ltd Business Operation Conditions
Table Business Operation of Can-Fite BioPharma Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Celgene Corp (Company Profile, Sales Data etc.)
4.7.1 Celgene Corp Profile
Table Celgene Corp Overview List
4.7.2 Celgene Corp Products & Services
4.7.3 Celgene Corp Business Operation Conditions
Table Business Operation of Celgene Corp (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 DermaXon LLC (Company Profile, Sales Data etc.)
4.8.1 DermaXon LLC Profile
Table DermaXon LLC Overview List
4.8.2 DermaXon LLC Products & Services
4.8.3 DermaXon LLC Business Operation Conditions
Table Business Operation of DermaXon LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Eisai (Company Profile, Sales Data etc.)
4.9.1 Eisai Profile
Table Eisai Overview List
4.9.2 Eisai Products & Services
4.9.3 Eisai Business Operation Conditions
Table Business Operation of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Immune Pharmaceuticals Inc (Company Profile, Sales Data etc.)
4.10.1 Immune Pharmaceuticals Inc Profile
Table Immune Pharmaceuticals Inc Overview List
4.10.2 Immune Pharmaceuticals Inc Products & Services
4.10.3 Immune Pharmaceuticals Inc Business Operation Conditions
Table Business Operation of Immune Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 INSYS Therapeutics Inc (Company Profile, Sales Data etc.)
4.11.1 INSYS Therapeutics Inc Profile
Table INSYS Therapeutics Inc Overview List
4.11.2 INSYS Therapeutics Inc Products & Services
4.11.3 INSYS Therapeutics Inc Business Operation Conditions
Table Business Operation of INSYS Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Kineta Inc (Company Profile, Sales Data etc.)
4.12.1 Kineta Inc Profile
Table Kineta Inc Overview List
4.12.2 Kineta Inc Products & Services
4.12.3 Kineta Inc Business Operation Conditions
Table Business Operation of Kineta Inc (Sales Revenue, Cost, Gross Margin)
4.13 KPI Therapeutics Inc (Company Profile, Sales Data etc.)
4.13.1 KPI Therapeutics Inc Profile
Table KPI Therapeutics Inc Overview List
4.13.2 KPI Therapeutics Inc Products & Services
4.13.3 KPI Therapeutics Inc Business Operation Conditions
Table Business Operation of KPI Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Krenitsky Pharmaceuticals Inc (Company Profile, Sales Data etc.)
4.14.1 Krenitsky Pharmaceuticals Inc Profile
Table Krenitsky Pharmaceuticals Inc Overview List
4.14.2 Krenitsky Pharmaceuticals Inc Products & Services
4.14.3 Krenitsky Pharmaceuticals Inc Business Operation Conditions
Table Business Operation of Krenitsky Pharmaceuticals Inc (Sales Revenue, Cost, Gross Margin)
4.15 MAKScientific LLC (Company Profile, Sales Data etc.)
4.15.1 MAKScientific LLC Profile
Table MAKScientific LLC Overview List
4.15.2 MAKScientific LLC Products & Services
4.15.3 MAKScientific LLC Business Operation Conditions
Table Business Operation of MAKScientific LLC (Sales Revenue, Cost, Gross Margin)
4.16 Metys Pharmaceuticals AG (Company Profile, Sales Data etc.)
4.16.1 Metys Pharmaceuticals AG Profile
Table Metys Pharmaceuticals AG Overview List
4.16.2 Metys Pharmaceuticals AG Products & Services
4.16.3 Metys Pharmaceuticals AG Business Operation Conditions
Table Business Operation of Metys Pharmaceuticals AG (Sales Revenue, Cost, Gross Margin)
4.17 Midatech Pharma US Inc (Company Profile, Sales Data etc.)
4.17.1 Midatech Pharma US Inc Profile
Table Midatech Pharma US Inc Overview List
4.17.2 Midatech Pharma US Inc Products & Services
4.17.3 Midatech Pharma US Inc Business Operation Conditions
Table Business Operation of Midatech Pharma US Inc (Sales Revenue, Cost, Gross Margin)
4.18 Mundipharma International Ltd (Company Profile, Sales Data etc.)
4.18.1 Mundipharma International Ltd Profile
Table Mundipharma International Ltd Overview List
4.18.2 Mundipharma International Ltd Products & Services
4.18.3 Mundipharma International Ltd Business Operation Conditions
Table Business Operation of Mundipharma International Ltd (Sales Revenue, Cost, Gross Margin)
4.19 Nemus Bioscience Inc (Company Profile, Sales Data etc.)
4.19.1 Nemus Bioscience Inc Profile
Table Nemus Bioscience Inc Overview List
4.19.2 Nemus Bioscience Inc Products & Services
4.19.3 Nemus Bioscience Inc Business Operation Conditions
Table Business Operation of Nemus Bioscience Inc (Sales Revenue, Cost, Gross Margin)
4.20 Neurocentrx Pharma Ltd (Company Profile, Sales Data etc.)
4.20.1 Neurocentrx Pharma Ltd Profile
Table Neurocentrx Pharma Ltd Overview List
4.20.2 Neurocentrx Pharma Ltd Products & Services
4.20.3 Neurocentrx Pharma Ltd Business Operation Conditions
Table Business Operation of Neurocentrx Pharma Ltd (Sales Revenue, Cost, Gross Margin)
4.21 Panacea Pharmaceuticals Inc (Company Profile, Sales Data etc.)
4.21.1 Panacea Pharmaceuticals Inc Profile
Table Panacea Pharmaceuticals Inc Overview List
4.21.2 Panacea Pharmaceuticals Inc Products & Services
4.21.3 Panacea Pharmaceuticals Inc Business Operation Conditions
Table Business Operation of Panacea Pharmaceuticals Inc (Sales Revenue, Cost, Gross Margin)
4.22 PeriphaGen Inc (Company Profile, Sales Data etc.)
4.22.1 PeriphaGen Inc Profile
Table PeriphaGen Inc Overview List
4.22.2 PeriphaGen Inc Products & Services
4.22.3 PeriphaGen Inc Business Operation Conditions
Table Business Operation of PeriphaGen Inc (Sales Revenue, Cost, Gross Margin)
4.23 PharmatrophiX Inc (Company Profile, Sales Data etc.)
4.23.1 PharmatrophiX Inc Profile
Table PharmatrophiX Inc Overview List
4.23.2 PharmatrophiX Inc Products & Services
4.23.3 PharmatrophiX Inc Business Operation Conditions
Table Business Operation of PharmatrophiX Inc (Sales Revenue, Cost, Gross Margin)
4.24 PledPharma AB (Company Profile, Sales Data etc.)
4.24.1 PledPharma AB Profile
Table PledPharma AB Overview List
4.24.2 PledPharma AB Products & Services
4.24.3 PledPharma AB Business Operation Conditions
Table Business Operation of PledPharma AB (Sales Revenue, Cost, Gross Margin)
4.25 Sova Pharmaceuticals Inc (Company Profile, Sales Data etc.)
4.25.1 Sova Pharmaceuticals Inc Profile
Table Sova Pharmaceuticals Inc Overview List
4.25.2 Sova Pharmaceuticals Inc Products & Services
4.25.3 Sova Pharmaceuticals Inc Business Operation Conditions
Table Business Operation of Sova Pharmaceuticals Inc (Sales Revenue, Cost, Gross Margin)
4.26 Virobay Inc (Company Profile, Sales Data etc.)
4.26.1 Virobay Inc Profile
Table Virobay Inc Overview List
4.26.2 Virobay Inc Products & Services
4.26.3 Virobay Inc Business Operation Conditions
Table Business Operation of Virobay Inc (Sales Revenue, Cost, Gross Margin)
4.27 WEX Pharmaceuticals Inc (Company Profile, Sales Data etc.)
4.27.1 WEX Pharmaceuticals Inc Profile
Table WEX Pharmaceuticals Inc Overview List
4.27.2 WEX Pharmaceuticals Inc Products & Services
4.27.3 WEX Pharmaceuticals Inc Business Operation Conditions
Table Business Operation of WEX Pharmaceuticals Inc (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Revenue 2016-2020, by Company, in USD Million
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Revenue Share in 2020, by Company, in USD Million
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Volume 2016-2020, by Company, in Volume
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Concentration, in 2020
Figure Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Market Concentration, in 2020
Figure Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment MMarket Concentration, in 2020
Figure South America Chemotherapy Induced Peripheral Neuropathy Treatment Market Concentration, in 2020
Figure Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Clinic
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Demand in Clinic, 2016-2020, in USD Million
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Demand in Clinic, 2016-2020, in Volume
6.1.2 Demand in Hospital
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Demand in Hospital, 2016-2020, in USD Million
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Demand in Hospital, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Demand in Others, 2016-2020, in USD Million
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Chemotherapy Induced Peripheral Neuropathy Treatment Demand Forecast 2021-2026, by Application, in USD Million
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Market Growth 2021-2026, by Application, in USD Million
Figure Chemotherapy Induced Peripheral Neuropathy Treatment Market Share in 2026, by Application, in USD Million
Table Chemotherapy Induced Peripheral Neuropathy Treatment Demand Forecast 2021-2026, by Application, in Volume
Table Chemotherapy Induced Peripheral Neuropathy Treatment Market Growth 2021-2026, by Application, in Volume
Table Chemotherapy Induced Peripheral Neuropathy Treatment Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Chemotherapy Induced Peripheral Neuropathy Treatment Production 2016-2020, by Region, in USD Million
Table Chemotherapy Induced Peripheral Neuropathy Treatment Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market 2016-2020, by Region, in USD Million
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Share 2016-2020, by Region, in USD Million
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market 2016-2020, by Region, in Volume
Table Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Growth 2016-2020, in USD Million
Figure North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2016-2020, by Country, in USD Million
Table North America Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Growth 2016-2020, in USD Million
Figure Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2016-2020, by Country, in USD Million
Table Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Growth 2016-2020, in USD Million
Figure South America Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2016-2020, by Country, in USD Million
Table South America Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast 2021-2026, by Region, in USD Million
Table Chemotherapy Induced Peripheral Neuropathy Treatment Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.